Last episode psychosis

Acta Psychiatrica Scandinavica

Volumn 119, Issue 6, 2009, Pages 417-418

  Munk Jørgensen, Povl ^a   Nielsen, Jimmi ^a   Nielsen, René Ernst ^a   Stahl, Stephen M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; EDITORIAL; HOMELESSNESS; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MENTAL HOSPITAL; PATIENT CARE; POPULATION; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RISK FACTOR; SCHIZOPHRENIA; SOCIAL INTERACTION;

DENMARK; EPISODE OF CARE; FEMALE; HOMELESS PERSONS; HOSPITALIZATION; HUMANS; LIFE EXPECTANCY; MALE; PSYCHIATRIC DEPARTMENT, HOSPITAL; SCHIZOPHRENIA;

EID: 65749084609     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01392.x     Document Type: Editorial

References (19)

1. Folsom D, Jeste DV. Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand 2002 105 : 404 413. (Pubitemid 34680810)
2. Volavka J, Czobor P, Sheitman B et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 2002 159 : 255 262. (Pubitemid 34126903)
3. Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiatry 2004 49 : 753 760. (Pubitemid 40094948)
4. Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007 68 (Suppl. 4 8 13. (Pubitemid 46762118)
5. Moller HJ. Course and long-term treatment of schizophrenic psychoses. Pharmacopsychiatry 2004 37 (Suppl. 2 126 135.
6. Oehl M, Hummer M, Fleischhacker WW. Compliance with antipsychotic treatment. Acta Psychiatr Scand 2000 102 (Suppl. 407 83 86. (Pubitemid 32115754)
7. Valenstein M, Copeland LA, Blow FC et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002 40 : 630 639.
8. Herings RM, Erkens JA. Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug Saf 2003 12 : 423 424. (Pubitemid 36903380)
9. Smelson DA, Dixon L, Craig T et al. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs 2008 22 : 903 916.
10. Leucht L, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007 116 : 317 333. (Pubitemid 47537428)
11. Copeland LA, Zeber JE, Pugh MJ, Mortensen EM, Restrepo MI, Lawrence VA. Postoperative complications in the seriously mentally ill: a systematic review of the literature. Ann Surg 2008 248 : 31 38.
12. Suzuki T, Uchida H, Tanaka KF et al. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. Int J Neuropsychopharmacol 2004 7 : 133 142. (Pubitemid 38823280)
13. Allison DB, Mentore JL, Heo M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999 156 : 1686 1696. (Pubitemid 29517559)
14. Wirshing DA, Wirshing WC, Kysar L et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999 60 : 358 363. (Pubitemid 29289721)
15. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997 171 : 502 508. (Pubitemid 27527317)
16. Saha S, Chant D, Mcgrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007 64 : 1123 1131. (Pubitemid 47529346)
17. Ösby U, Correia N, Brandt L, Ekbom A, Sparén P. Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study. BMJ 2000 321 : 483 484. (Pubitemid 30623604)
18. Albus M, Hubmann W, Ehrenberg C et al. Neuropsychological impairment in first-episode and chronic schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 1996 246 : 249 255. (Pubitemid 26252542)
19. Norholm V, Bech P. Quality of life assessment in schizophrenia: applicability of the Lehman Quality of Life Questionnaire (TL-30). Nord J Psychiatry 2007 61 : 438 442.